What is LFMD (LFMD) stock price today?

LFMD (LFMD) is currently trading at $3.40, down 7.61% today.

What is LFMD P/E ratio?

LFMD's P/E ratio is -18.83. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is LFMD return on equity (ROE)?

LFMD's return on equity (ROE) is -30.43%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is LFMD's market cap?

LFMD has a market capitalization of $164.43M.

NASDAQ · Medical - Pharmaceuticals

LFMD (LFMD) Stock

$3.40 -7.61% NASDAQ: LFMD Healthcare

Valuation

Metric	Value
Price	$3.40
Market Cap	$164.43M
P/E Ratio	-18.83
P/B Ratio	9.10
P/S Ratio	0.93
EPS (TTM)	$-0.23
52-Week High	$15.84
52-Week Low	$2.56
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-30.43%
ROA	-10.00%
ROCE	-34.78%
Gross Margin	-4.12%
Operating Margin	-4.12%
Net Margin	-7.41%
Debt/Equity	0.41
Current Ratio	1.24

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$93.0M	$119.0M	$153.0M	$212.0M	$194.0M
Operating Profit	$-54.0M	$-43.0M	$-14.0M	$-16.0M	$-8.0M
Net Profit	$-61.0M	$-46.0M	$-21.0M	$-19.0M	$-7.0M
EPS	$-2.27	$-1.57	$-0.70	$-0.53	$-0.23
Op Margin	-58.5%	-36.5%	-9.5%	-7.6%	-4.0%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$50.0M	$26.0M	$58.0M	$72.0M	$70.0M
Total Liabilities	$24.0M	$33.0M	$53.0M	$77.0M	$47.0M
Cash	$41.0M	$4.0M	$33.0M	$35.0M	$37.0M
Borrowings	$2.0M	$4.0M	$19.0M	$25.0M	$6.0M

Latest News

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock GlobeNewswire · Jun 23, 2026 LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection GlobeNewswire · Jun 22, 2026 CareDx (CDNA) Moves 11.5% Higher: Will This Strength Last? Zacks · Jun 19, 2026 How The Story Is Evolving For LifeMD (LFMD) With An Unchanged Fair Value View Simply Wall St. · Jun 4, 2026 LifeMD Names Umesh Sripad as Chief Technology Officer MT Newswires · Jun 1, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-33.0M	$-23.0M	$9.0M	$18.0M	$8.0M
Investing Cash Flow	$-7.0M	$-27.0M	$-17.0M	$-23.0M	$5.0M
Financing Cash Flow	$1.0M	$0	$-1.0M	$-1.0M	$-1.0M
Net Cash Flow	$32.0M	$-37.0M	$29.0M	$2.0M	$2.0M
Free Cash Flow	$-36.0M	$-36.0M	$0	$6.0M	$6.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	—
FCF Yield	7.29%
Quick Ratio	0.98
Interest Coverage	-8.00
Return 1Y	-60.16%
Return 3Y	10.00%
Return 5Y	-52.63%

Ownership

Insiders Held13.91%

Institutions Held40.88%

Institutions Float Held47.49%

Institutional Holder	Shares	Report Date
Blackrock Inc.	2,809,025	2026-03-31
Vanguard Capital Management LLC	1,663,696	2026-03-31
Royce & Associates LP	1,201,651	2026-03-31
Renaissance Technologies, LLC	1,118,325	2026-03-31
State Street Corporation	1,075,408	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AAPLApple Inc.	$313.33	+0.29%	37.72	$4.60T	0.34%
MSFTMicrosoft Corporation	$499.99	+0.03%	22.95	$3.71T	0.94%
GOOGLAlphabet Inc.	$354.30	-0.96%	27.68	$4.29T	0.23%
AMZNAmazon.com, Inc.	$274.48	+0.82%	28.76	$2.95T	0.00%
METAMeta Platforms, Inc.	$592.10	+0.37%	21.47	$1.51T	0.35%

About LFMD

LFMD is led by CEO Justin Schreiber, publicly traded since 2008.

LFMD stock trades at $3.40 with a market capitalization of $164.43M. The stock is valued at a price-to-earnings (P/E) ratio of -18.83, price-to-book of 9.10, price-to-sales of 0.93. Over the past 52 weeks the stock has ranged between $2.56 and $15.84, and currently trades 78.5% below its 52-week high.

On profitability, LFMD generates a return on equity (ROE) of -30.43%, return on capital employed of -34.78%, an operating margin of -4.12%, a net profit margin of -7.41%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides